R&D Systems代理373-TC-050/CF Recombinant Human TrkC Fc Chimera Protein, CF (50 UG)

2025-06-28

货号:373-TC-050/CF

品牌:R&D Systems

规格:50ug

目录价:¥4490.00

市场价格:¥3592.00

会员价格:¥3592.00

  • 到货时间:3~4周

    金山科研平台,产品价格货期咨询微信:jinshanbio Source:Mouse myeloma cell line, NS0-derived Accession #:Q96CY4 N-terminal Sequence Analysis:Cys32 Structure:Disulfide-linked homodimer Purity:>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. Endotoxin Level: Predicted Molecular Mass:72 kDa (monomer) SDS-PAGE:130-150 kDa, reducing conditions Activity:Measured by its ability to inhibit NT-3-induced proliferation of BaF‑TrkB‑BD mouse pro‑B cells transfected with TrkB.The ED50 for this effect is typically 0.05 - 0.2 µg/mL in the presence of 40 ng/mL of rhNT-3. Molecule Information: TrkC Long Name: Neurotrophic Tyrosine Kinase Receptor C Aliases: NTRK3 Entrez Gene IDs: 4916 (Human); 18213 (Mouse); 29613 (Rat) Background: TrkC View TrkC IHC images. Members of the Tyrosine Kinase Receptor (Trk) family (TrkA, TrkB, and TrkC) of receptor tyrosine kinases act as receptors for the neurotrophin family: BDNF, NGF, NT-3, and NT-4. Trks exhibit selectivity for specific neurotrophins. TrkA, TrkB and TrkC preferentially bind NGF, NT-4 and BDNF, and NT-3, respectively. All Trk family proteins share a common structural organization consisting of an extracellular region with two cysteine-rich domains, a cluster of three leucine-rich motifs, and two immunoglobulin-like domains, and an intracellular region that contains the tyrosine kinase domain. They are best known for their regulation of neuronal survival and axon outgrowth. TrkC is predominantly expressed in the central nervous system.

    © 金山科研平台是专业的授权总代理区域代理经销平台。
    © 如需询价,请加客服QQ:1749072012 、客服微信:jinshanbio,或发送邮件到1749072012@qq.com
    © 平台为生命科学研究相关领域提供一站式耗材试剂仪器解决方案和采购服务,数据资源基于CC协议。
    © 本文地址:https://www.16ao.com/thread-134762.htm
    © R&D Systems代理373-TC-050/CF Recombinant Human TrkC Fc Chimera Protein, CF (50 UG),产品报价联系微信jinshanbio
  • 产品询价需求提交
    产品询价请加微信:jinshanbio
    返回